Current research into semaglutide are uncovering remarkable applications beyond current use for type 2 diabetes. Scientists are actively analyzing the way this GLP-1 receptor agonist affects metabolic health, the heart, and even brain health. The results suggest a extensive array of future treatments, inspiring more exploration and clinical trials.